About
Technology
Issues
FAQ
Links
Official Page
AB0758 Change in Weight from Baseline during the Palace Clinical Trial Program with Apremilast, an Oral Phosphodiesterase 4 Inhibitor: Pooled Results from 3 Phase 3, Randomized, Controlled Trials
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.